Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
OBJECTIVES: I. Evaluate the sleep-entrained patterns of gonadotropin-releasing hormone (GnRH) and sex steroid secretion in normal and hypogonadal children.
II. Examine the acute effects of sex steroids on the sleep-entrained patterns of GnRH secretion in pubertal children and normal adults, either by stimulation of endogenous production with pulsatile injection or by intravenous infusion of GnRH.
III. Examine the role of endogenous opioids by means of opioid receptor blockade in the sex steroid regulation of GnRH secretion in pubertal children and normal adults.
| Condition |
|---|
|
Hypogonadism Precocious Puberty |
| Study Type: | Observational |
| Study Design: | Primary Purpose: Screening |
| Study Start Date: | April 1993 |
PROTOCOL OUTLINE: This project involves several clinical protocols that study the regulation and role of pulsatile gonadotropin-releasing hormone (GnRH) secretion.
Studies include dynamic and repeated stimulation tests of pulsatile GnRH; plasma luteinizing hormone, follicular-stimulating hormone, testosterone (T), estradiol (E2), and GnRH measurements at cyclic and episodic intervals; and evaluation of adrenal androgen patterns.
Circadian rhythms of GnRH secretion are monitored during sleep and awake hours. Growth hormone secretory patterns and responses to provocative stimuli are studied as clinically indicated.
Selected participants undergo an assessment of pituitary responsiveness following T, E2, and/or naloxone infusions. The suppressive effects of E2 are also studied during the early follicular phase of the menstrual cycle.
Endocrinologically normal children and normal adult men and women are also studied.
Eligibility| Ages Eligible for Study: | 7 Years to 35 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
- Suspected or proven hypothalamic-pituitary-gonadal dysfunction, i.e.: Significant short stature and possible hypopituitarism Delayed adolescence Precocious puberty Isolated growth hormone deficiency (IGHD)Primary hypogonadism
- Women are also studied, including those with the following disorders: Infertility Oligo- or amenorrhea Hirsutism
--Patient Characteristics--
- Age: 7 to 16 (18 to 35 for women and volunteers)
- Other: No pregnant or nursing women No prisoners Not in neuropsychiatric institute or other facility for mental illness
Contacts and Locations| United States, Michigan | |
| University of Michigan Health Systems | |
| Ann Arbor, Michigan, United States, 48109 | |
| Study Chair: | Carol M. Foster | University of Michigan |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00004335 History of Changes |
| Other Study ID Numbers: | 199/11894, UMMC-271 |
| Study First Received: | October 18, 1999 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Center for Research Resources (NCRR):
|
endocrine disorders growth hormone deficiency hypogonadism precocious puberty rare disease |
Additional relevant MeSH terms:
|
Hypogonadism Puberty, Precocious Gonadal Disorders Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 22, 2013